Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024020 · ClinicalTrials.gov registry record
Chronic Insomnia and CSF Markers of Dementia
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 30
- Enrollment target
NCT04024020: Completed study, sponsored by University of Pennsylvania.
NCT04024020 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04024020 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep disturbance often precedes and increases risk for dementia by several years.The purpose of this study is to examine the relationship between chronic insomnia and dementia biomarkers and orexin levels found in cerebrospinal fluid (CSF). Fifteen adults age 30-50 with chronic insomnia and age- and gender-matched good sleepers will undergo overnight polysomnography and CSF sampling in the morning.
Primary Outcome
CSF levels of the proteins Abeta40 and Abeta42
Interventions
- OTHER lumbar puncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-10-31 |
What the finished NCT04024020 record still lists
NCT04024020 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which lumbar puncture is the first listed.
NCT04024020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04024020 about?
NCT04024020 is a clinical study titled "Chronic Insomnia and CSF Markers of Dementia". The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasin...
What is the current status of trial NCT04024020?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-01-01. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT04024020?
The interventions under investigation include: lumbar puncture (OTHER).
Who is sponsoring clinical trial NCT04024020?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI